Anxiolytic-like effects observed in rats exposed to the elevated zero-maze following treatment with 5-HT2/5-HT3/5-HT4 ligands (Q30359106)

15 October 2017

Anxiolytic-like effects observed in rats exposed to the elevated zero-maze following treatment with 5-HT2/5-HT3/5-HT4 ligands (English)

1 reference

15 October 2017

Rob Bell

1

1 reference

15 October 2017

Aaron A Duke

2

1 reference

15 October 2017

Paula E Gilmore

3

1 reference

15 October 2017

Deaglan Page

4

1 reference

15 October 2017

Laurent Bègue

5

1 reference

15 October 2017

language of work or name

English

0 references

publication date

24 January 2014

1 reference

15 October 2017

1 reference

15 October 2017

4

1 reference

15 October 2017

3881

1 reference

Creative Commons Attribution 3.0 Unported

15 October 2017

start time

24 January 2014

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Animal models of depression and anxiety: What do they tell us about human condition?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5379192

Comparison of the elevated plus and elevated zero mazes in treated and untreated male Sprague–Dawley rats: Effects of anxiolytic and anxiogenic agents

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5379192

The dual role of serotonin in defense and the mode of action of antidepressants on generalized anxiety and panic disorders.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5379192

Strain- and model-dependent effects of chlordiazepoxide, L-838,417 and zolpidem on anxiety-like behaviours in laboratory mice

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5379192

What's wrong with my mouse model? Advances and strategies in animal modeling of anxiety and depression.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5379192

The ascent of mouse: advances in modelling human depression and anxiety

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5379192

Ethological and temporal analyses of anxiety-like behavior: the elevated plus-maze model 20 years on.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5379192

Do animal models of anxiety predict anxiolytic-like effects of antidepressants?

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5379192

5-HT(3) receptor antagonists and anxiety; a preclinical and clinical review

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5379192

Effects of centrally administered anxiolytic compounds in animal models of anxiety

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5379192

Responses of Swiss-Webster mice to repeated plus-maze experience: further evidence for a qualitative shift in emotional state?

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5379192

Anxiolytic-like actions of the selective 5-HT4 receptor antagonists SB 204070A and SB 207266A in rats.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5379192

SB 242084, a selective and brain penetrant 5-HT2C receptor antagonist

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5379192

Effects of 5-HT4 receptor antagonists on rat behaviour in the elevated plus-maze test

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5379192

3 June 2018

Central 5-HT4 receptors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5379192

Factor analysis of spatiotemporal and ethological measures in the murine elevated plus-maze test of anxiety

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5379192

Pharmacological characterization of two novel and potent 5-HT4 receptor agonists, RS 67333 and RS 67506, in vitro and in vivo

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5379192

Behavioural and pharmacological characterisation of the elevated "zero-maze" as an animal model of anxiety.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5379192

5-Hydroxytryptamine-interacting drugs in animal models of anxiety disorders: More than 30 years of research

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5379192

A benzodiazepine used in the treatment of insomnia phase-shifts the mammalian circadian clock

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5379192

Serotonin receptor subtype agonists: differential effects on sensorimotor reactivity measured with acoustic startle

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5379192

Anxiolytic-like effects of 5-HT2 ligands on three mouse models of anxiety

3 June 2018

1 reference

Elevated zero maze: a paradigm to evaluate antianxiety effects of drugs

21 January 2018

1 reference

Implication of 5-HT2 receptor subtypes in the mechanism of action of antidepressants in the four plates test

21 January 2018

1 reference

Behavioral effects of systemically administered MK-212 are prevented by ritanserin microinfusion into the basolateral amygdala of rats exposed to the elevated plus-maze.

21 January 2018

1 reference

The effects of cholecystokinin A and B receptor antagonists on exploratory behaviour in the elevated zero-maze in rat.

21 January 2018

1 reference

Ethopharmacological analysis of 5-HT ligands on the rat elevated plus-maze

21 January 2018

1 reference

Acute and chronic effects of gepirone and fluoxetine in rats tested in the elevated plus-maze: an ethological analysis.

21 January 2018

1 reference

Ethopharmacological analysis of rat behavior on the elevated plus-maze.

21 January 2018

1 reference

Anxiogenic-like effects of fluprazine and eltoprazine in the mouse elevated plus-maze: profile comparisons with 8-OH-DPAT, CGS 12066B, TFMPP and mCPP.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5379192

Antidepressant-like effects of SR 57227A, a 5-HT3 receptor agonist, in rodents

26 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24457553

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The influence of ritanserin, a serotonin antagonist, in anxiety disorders: a double-blind placebo-controlled study versus lorazepam

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24457553

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Excitatory and inhibitory effects of serotonin on sensorimotor reactivity measured with acoustic startle

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SREP03881

1 reference

Dimensions Publication ID

15 October 2017

0 references

1 reference

15 October 2017

PubMed publication ID

24457553

1 reference